Daan Gene Co., Ltd. (SHE:002030)
6.02
+0.01 (0.17%)
May 23, 2025, 2:45 PM CST
Daan Gene Revenue
Daan Gene had revenue of 169.14M CNY in the quarter ending March 31, 2025, a decrease of -14.71%. This brings the company's revenue in the last twelve months to 823.85M, down -20.64% year-over-year. In the year 2024, Daan Gene had annual revenue of 853.02M, down -27.76%.
Revenue (ttm)
823.85M
Revenue Growth
-20.64%
P/S Ratio
10.26
Revenue / Employee
476.22K
Employees
1,730
Market Cap
8.45B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 853.02M | -327.87M | -27.76% |
Jan 1, 2024 | 1.18B | -10.87B | -90.20% |
Jan 1, 2023 | 12.05B | 4.38B | 57.17% |
Jan 1, 2022 | 7.66B | 2.32B | 43.49% |
Dec 31, 2020 | 5.34B | 4.24B | 386.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |